BioCentury This Week
391 episodes - English - Latest episode: 5 days ago - ★★★★★ - 11 ratingsBioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Special Report - Collaborating Against the Challenges of COVID Part 2: A conversation with NBIR President Jay Bradner
May 14, 2020 00:00 - 21 minutes - 14.7 MBSpecial Edition - Collaborating Against the Challenges of COVID Part 2: A conversation with NBIR President Jay Bradner
May 14, 2020 00:00 - 21 minutes - 14.7 MBSpecial Edition - Collaborating Against the Challenges of COVID Part 1: A conversation with Novartis' John Tsai
May 13, 2020 23:00 - 20 minutes - 14.2 MBSpecial Report: Collaborating Against the Challenges of COVID Part 1: A conversation with Novartis' John Tsai
May 13, 2020 23:00 - 20 minutes - 14.2 MBSpecial Report - Collaborating Against the Challenges of COVID Part 1: A conversation with Novartis' John Tsai
May 13, 2020 23:00 - 20 minutes - 14.2 MBEpisode 5 S1: Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
May 12, 2020 13:00 - 15 minutes - 10.6 MBEp. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
May 12, 2020 13:00 - 15 minutes - 10.6 MBEpisode 5: Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
May 12, 2020 13:00 - 15 minutes - 10.6 MBEpisode 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
May 12, 2020 13:00 - 15 minutes - 10.6 MBSpecial Report - Getting Real about COVID-19 Data Part 1: A conversation with Amy Abernethy
May 08, 2020 21:00 - 21 minutes - 15 MBAmy Abernethy, FDA’s principal deputy commissioner and acting CIO describe in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.
Special Report: Getting Real about COVID-19 Data Part 2: A conversation with Mark McClellan
May 08, 2020 21:00 - 16 minutes - 11.2 MBMark McClellan, director of the Duke-Margolis Center for Health Policy at Duke University describes in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.
Special Report - Getting Real about COVID-19 Data Part 2: A conversation with Mark McClellan
May 08, 2020 21:00 - 16 minutes - 11.2 MBMark McClellan, director of the Duke-Margolis Center for Health Policy at Duke University describes in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.
Special Edition - Getting Real about COVID-19 Data Part 1: A conversation with Amy Abernethy
May 08, 2020 21:00 - 21 minutes - 15 MBAmy Abernethy, FDA’s principal deputy commissioner and acting CIO describe in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.
Special Edition - Getting Real about COVID-19 Data Part 2: A conversation with Mark McClellan
May 08, 2020 21:00 - 16 minutes - 11.2 MBMark McClellan, director of the Duke-Margolis Center for Health Policy at Duke University describes in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.
Special Report: Getting Real about COVID-19 Data Part 1: A conversation with Amy Abernethy
May 08, 2020 21:00 - 21 minutes - 15 MBAmy Abernethy, FDA’s principal deputy commissioner and acting CIO describe in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.
Special Report: Consummating a deal under lockdown
May 06, 2020 21:00 - 25 minutes - 17.8 MBIn a special podcast interview with BioCentury’s Editor in Chief Simone Fishburn, James Sabry, Global Head of Pharma Partnering at Roche and Mike Gilman CEO of Arrakis discuss consummating this deal while under lockdown of COVID-19.
Special Edition - Consummating a deal under lockdown
May 06, 2020 21:00 - 25 minutes - 17.8 MBIn a special podcast interview with BioCentury’s Editor in Chief Simone Fishburn, James Sabry, Global Head of Pharma Partnering at Roche and Mike Gilman CEO of Arrakis discuss consummating this deal while under lockdown of COVID-19.
Special Report - Consummating a deal under lockdown
May 06, 2020 21:00 - 25 minutes - 17.8 MBIn a special podcast interview with BioCentury’s Editor in Chief Simone Fishburn, James Sabry, Global Head of Pharma Partnering at Roche and Mike Gilman CEO of Arrakis discuss consummating this deal while under lockdown of COVID-19.
Episode 4: End of the beginning for vaccines and the post-pandemic future
May 05, 2020 16:00 - 15 minutes - 10.7 MBBioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.
Episode 4 - End of the beginning for vaccines and the post-pandemic future
May 05, 2020 16:00 - 15 minutes - 10.7 MBBioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.
Ep. 4 - End of the beginning for vaccines and the post-pandemic future
May 05, 2020 16:00 - 15 minutes - 10.7 MBBioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.
BioCentury This Week: Episode 4 - End of the beginning for vaccines and the post-pandemic future
May 05, 2020 16:00 - 15 minutes - 10.7 MBBioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.
Episode 4 S1: End of the beginning for vaccines and the post-pandemic future
May 05, 2020 16:00 - 15 minutes - 10.7 MBBioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.
Episode 3 - Surveying the Landscape for Biopharmas
April 28, 2020 13:00 - 14 minutes - 10 MBBioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.
Episode 3: Surveying the Landscape for Biopharmas
April 28, 2020 13:00 - 14 minutes - 10 MBBioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.
BioCentury This Week: Episode 3 - Surveying the Landscape for Biopharmas
April 28, 2020 13:00 - 14 minutes - 10 MBBioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.
Episode 3 S1: Surveying the Landscape for Biopharmas
April 28, 2020 13:00 - 14 minutes - 10 MBBioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.
Ep. 3 - Surveying the Landscape for Biopharmas
April 28, 2020 13:00 - 14 minutes - 10 MBBioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.
Special Report: Interview with FDA Commissioner Stephen Hahn
April 27, 2020 16:00 - 17 minutes - 12.1 MBFDA Commissioner Stephen Hahn discusses the agency's response to COVID-19.
Special Report - Interview with FDA Commissioner Stephen Hahn
April 27, 2020 16:00 - 17 minutes - 12.1 MBFDA Commissioner Stephen Hahn discusses the agency's response to COVID-19.
BioCentury This Week: Special Report - Interview with FDA Commissioner Stephen Hahn
April 27, 2020 16:00 - 17 minutes - 12.1 MBFDA Commissioner Stephen Hahn discusses the agency's response to COVID-19.
BioCentury This Week: Episode 2 - Consorting to beat COVID-19
April 23, 2020 13:00 - 14 minutes - 10 MBHow industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.
BioCentury This Week: Episode 1 - Racing to Create Countermeasures
April 23, 2020 13:00 - 16 minutes - 11 MBIt has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19.
Episode 2 - Consorting to beat COVID-19
April 23, 2020 13:00 - 14 minutes - 10 MBHow industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.
Ep. 2 - Consorting to beat COVID-19
April 23, 2020 13:00 - 14 minutes - 10 MBHow industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.
Episode 2: Consorting to beat COVID-19
April 23, 2020 13:00 - 14 minutes - 10 MBHow industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.
Episode 2 S1: Consorting to beat COVID-19
April 23, 2020 13:00 - 14 minutes - 10 MBHow industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.
Episode 1 S1: Racing to Create Countermeasures
April 22, 2020 13:00 - 16 minutes - 11 MBIt has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19.
Ep. 1 - Racing to Create Countermeasures
April 22, 2020 13:00 - 16 minutes - 11 MBIt has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19.
Episode 1: Racing to Create Countermeasures
April 22, 2020 13:00 - 16 minutes - 11 MBIt has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19.
Episode 1 - Racing to Create Countermeasures
April 22, 2020 13:00 - 16 minutes - 11 MBIt has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by biopharma companies and other researchers in developing diagnostics, therapies and vaccines against the virus that causes COVID-19.